NRIX
Nurix Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.63 / 10
Outperform
Technical evaluation scores 6.63/10, highlighting bullish signals such as Long Upper Shadow and MACD Golden Cross, with a neutral Long Lower Shadow. Recent five‑day data show limited new signals, suggesting a calm but still optimistic technical outlook.
Analysis Checks(3/3)
Long Upper Shadow
Score7.5/10
Win Rate60.00%
Hist. Signals40
Avg Return3.40%
Score7.5/10
Win Rate60.00%
Hist. Signals40
Avg Return3.40%
MACD Golden Cross
Score6.24/10
Win Rate57.14%
Hist. Signals7
Avg Return1.86%
Score6.24/10
Win Rate57.14%
Hist. Signals7
Avg Return1.86%
Long Lower Shadow
Score6.15/10
Win Rate56.00%
Hist. Signals25
Avg Return0.83%
Score6.15/10
Win Rate56.00%
Hist. Signals25
Avg Return0.83%
Long Upper Shadow
Score7.5/10
Win Rate60.00%
Hist. Signals40
Avg Return3.40%
Score7.5/10
Win Rate60.00%
Hist. Signals40
Avg Return3.40%
Long Lower Shadow
Score6.15/10
Win Rate56.00%
Hist. Signals25
Avg Return0.83%
Score6.15/10
Win Rate56.00%
Hist. Signals25
Avg Return0.83%
MACD Golden Cross
Score6.24/10
Win Rate57.14%
Hist. Signals7
Avg Return1.86%
Score6.24/10
Win Rate57.14%
Hist. Signals7
Avg Return1.86%
Technical Analysis of NRIX?
- NRIX presents a Outperform setup with a Technical Score of 6.63/10. Key technical indicators highlight an RSI of 48.82 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 16.46. Traders should monitor key support at 14.03 and resistance at 14.83.
